Improvement in clinical signs and cellular immunity of dogs with visceral leishmaniasis using the immunomodulator P-MAPA

The immunomodulator P-MAPA promoted the remission of clinical signs and reduced IL-10 levels and the parasite load of dogs with symptomatic leishmaniasis, while increase cellular immunity.